Tobramycin

GPTKB entity

Statements (71)
Predicate Object
gptkbp:instanceOf antibiotic
gptkbp:approves gptkb:FDA
gptkbp:availableIn generic drug
gptkbp:brand Nebcin
TOBI
gptkbp:built Streptomyces tenebrarius
gptkbp:chemicalFormula C18H37N5O9
gptkbp:contraindication renal impairment
allergy to aminoglycosides
gptkbp:drugInterdiction renal excretion
gptkbp:endOfLife 2-3 hours
gptkbp:formulation ophthalmic solution
inhalation powder
gptkbp:hasActivities broad-spectrum
https://www.w3.org/2000/01/rdf-schema#label Tobramycin
gptkbp:impact meningitis
pneumonia
sepsis
cystic fibrosis
skin infections
otitis media
bacterial conjunctivitis
urinary tract infections
endocarditis
bacterial pneumonia
bacterial meningitis
bacterial throat infections
bacterial arthritis
bacterial bloodstream infections
bacterial central nervous system infections
bacterial dental infections
bacterial ear infections
bacterial endophthalmitis
bacterial eye infections
bacterial gastrointestinal infections
bacterial genital infections
bacterial heart infections
bacterial intra-abdominal infections
bacterial joint infections
bacterial keratitis
bacterial lung infections
bacterial oral infections
bacterial osteomyelitis
bacterial pelvic infections
bacterial perianal infections
bacterial rectal infections
bacterial respiratory and systemic infections
bacterial respiratory infections
bacterial respiratory tract infections
bacterial sepsis
bacterial sinus infections
bacterial skin and soft tissue infections
bacterial skin infections
bacterial soft tissue infections
bacterial systemic infections
bacterial urinary tract infections
bacterial vaginal infections
bacterial wound infections
bone infections
gptkbp:interactsWith muscle relaxants
other nephrotoxic drugs
gptkbp:issuedBy injection
inhalation solution
gptkbp:locatedIn 1967
gptkbp:route intravenous
topical
gptkbp:sideEffect nephrotoxicity
ototoxicity
gptkbp:targets Pseudomonas aeruginosa
gptkbp:triggerType inhibits protein synthesis
gptkbp:usedFor bacterial infections